Hi, what are you looking for?
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
“Bloomberg” has raised the possibility that Israel Chemicals Ltd. (TASE: ICL) could take advantage of its imminent public offering on the New York...
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
– Pharmaceutical company Perrigo has yet to be sold and already major business publications are speculating on what its sale will mean to the TASE....
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ ...
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical...
– – Last year, Rami Levy joined BTI, the group of businesspeople that supports peace with the Palestinians for the sake of the economy....
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...